J Clin Epidemiol
http://www.ncbi.nlm.nih.gov/pubmed/30708175
https://connects.catalyst.harvard.edu/Profiles/profile/117480448
The timing and frequency of trial inclusion in systematic reviews of type 2 diabetes drugs was associated with trial characteristics.
J Clin Epidemiol
http://www.ncbi.nlm.nih.gov/pubmed/30708175
https://connects.catalyst.harvard.edu/Profiles/profile/117480448